This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Learn to detect early warning signs of a failing budget, then adjust spending categories and plan to safeguard your finances.
11,501 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A single viral moment can ripple through markets and your wallet. This guide explains how media buzz affects money de...
Gold and silver slid this week as geopolitical risk and higher oil costs pressured bullion, while Bitcoin bucked the ...
A deadly LaGuardia collision puts the spotlight on air-traffic control fatigue, staffing gaps, and how these issues r...
MaxCyte's 2025 earnings journey hinges on platform momentum, partnerships, and cash discipline. This guide breaks dow...
A 40-year-old Democrat who owns a fitness company focused on pregnant and postpartum women pulled off a tight victory...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
Quantum computing stocks ionq, Rigetti, and D-Wave have captured investor imaginations with big promises and big vola...
Bitcoin has cooled from its peak, but a smarter buy may lie in a scalable altcoin. This article breaks down why Polyg...
Tourist crowds driven by social media push up prices and squeeze housing in popular spots. This report tracks how ove...
When homes linger on the market, buyers gain negotiating power and lenders adjust terms. This guide explains how stal...